Senior Data Scientist, Aignostics

Large-scale Machine Learning

Salary not provided
Python
Linux
Senior level
Berlin
Aignostics

AI-powered precision diagnostics assisting drug development and clinical research

Open for applications

Aignostics

AI-powered precision diagnostics assisting drug development and clinical research

21-100 employees

HealthcareB2BArtificial IntelligenceBiologyData Analysis

Open for applications

Salary not provided
Python
Linux
Senior level
Berlin

21-100 employees

HealthcareB2BArtificial IntelligenceBiologyData Analysis

Company mission

Aignostics' mission is to help take drug research from visual estimations under a microscope to precise analysis and quantification

Company mission

Aignostics' mission is to help take drug research from visual estimations under a microscope to precise analysis and quantification

Some candidates hear
back within 2 weeks

47% employee growth in 12 months

Our take

Manual microscopes are an incredible advancement in medical history. They provide an evaluation of tissue samples that enable the diagnosis of cancer as well as multiple degenerative, infectious and inflammatory diseases. With this said, there has been a worldwide increase in the numbers and complexity of cancer cases, as well as a predicted global shortage of pathologists. Manual analysis does not have the precision and capability to provide deeper conclusions from data to support the precision medicine and drug development processes of the future.

Aignostics recognise this issue. They are an interdisciplinary team of machine learners, data scientists, pathologists, software engineers and business professionals dedicated to taking explainable AI from their research lab into the wider world.

Aignostics plan to expand its portfolio in pharmaceutical research and fund longer-term projects that are aimed at developing companion/complementary diagnostics (CDx) applications for clinical routine. It will also increase its focus on the US market, leveraging its already considerable presence in Europe to make the jump across the Atlantic.

Steph headshot

Steph

Company Specialist at Welcome to the Jungle

Company values

  • Humility and respect: We want to be an idea meritocracy, where the best ideas win, not the loudest or most ‘senior’ voices. We think humility and respect are the basis for this. We therefore live tolerance and respect of other views, religions, sexual orientations and life models, and generally encourage direct and open communication
  • Integrity: We strive to do what’s right and fair. We don’t lie, and we also don’t overpromise, neither to each other, nor to our partners, clients, or investors. We give honest scientific opinions and we don’t shy away from the truth. Being a trusted partner is key to our success. We can admit mistakes and we try to learn from them
  • Teamwork: Developing pathology AI is a truly multidisciplinary problem, in a fast-moving technological field. We collaborate closely, and being a true team player is a must. All of us are “coachable”, can take honest feedback, and keep an open mind to change our approaches. We want to learn from each other and help each other shine!
  • Mission driven: We have a big mission, and we operate with a sense of urgency to achieve it. We rely on each other to take ownership and responsibility, and we constantly challenge each other to become better. At the same time, we value flexible working models and believe that a healthy work-life-balance is the basis for good performance

Funding (last 2 of 5 rounds)

Oct 2024

$34m

SERIES B

Sep 2022

$14.8m

SERIES A

Total funding: $55m

Leadership

Viktor Matyas

(CEO)

Viktor has experience as a Research Analyst at Arthur D Little, and Junior Engagement Manager at McKinsey.

Previously Intern at Google and Researcher at Berlin Institute of Technology.

Jobs (11)

All locations

Software Engineering

Finance, Legal & Compliance